|
|
|
|
|
Market Research Report
Beauty Drugs: Consumer Perceptions and Blurring Boundaries in the Global Cosmetics and Toiletries Market
| Published by |
Euromonitor International |
| Published |
December, 2007 |
Product code |
58330 |
| Content info |
Chapters: 7 / Tables: 23 |
| Price |
|
|
This publication has been discontinued on July 19, 2011.
Abstract
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive
environment
- Regional coverage
- Western Europe; Eastern Europe; North America; Latin America;
Asia-Pacific; Oceania; Africa and the Middle East
Table of Contents
- EXECUTIVE SUMMARY
- BLURRING OF BOUNDARIES
- INGREDIENTS
- KEY CONSUMER AND MARKET DRIVERS
- CORE MARKETS
- FUTURE TRENDS
- Product development and innovation
- Customer and product segmentation
- Market drivers
- Legislative change and market impact
- DEFINITIONS
- CHANGING BOUNDARIES
- Chart 1 Changing Category Boundaries
- ' PREMIUM/MASS' DEFINITIONS
- INGREDIENTS
- OVERVIEW
- NATURAL INGREDIENTS
- Learn Latin
- Soap and water
- Dangerous ingredients?
- Chart 2 How Ingredients Affect the Skin
- ' ACTIVE' INGREDIENTS
- Retinoids
- Hydroxy acids
- Chart 3 Regional Shares Total % Volume Sales of Hydroxy Acids 2006
- ANTI-OXIDANTS
- Peptides
- Collagen
- Chart 4 Regional Shares Total % Volume Sales of Collagen 2006
- Growth factors
- Hormones
- Botulinum toxin -- also known as Botox
- Skin lightening
- LEGISLATION
- OVERVIEW
- TAXONOMY OF BEAUTY -- WHERE DOES THE PRODUCT FIT?
- WALKING THE TIGHTROPE -- THE FINE LINE BETWEEN COSMETICS
- AND DRUGS
- KEY CONSUMER AND MARKET DRIVERS
- THE INTERPLAY BETWEEN COMPANIES AND CUSTOMERS
- Chart 5 Categories -- Traditional and Modern
- KEY CONSUMER DRIVERS
- Ageing population
- Western Boomers demand to stay young
- Gen X knows it needs to stay young
- Urbanisation -- shopping, affluence and stress
- Emerging middle class
- Declining middle class?
- The ability to buy -- beauty for the affluent
- Does age compression give you wrinkles?
- Skin care, sun and smoking
- A universal desire for beauty -- globalising
- standards?
- The evolution of skin care -- an inflationary process?
- Chart 6 Skin Care Evolves
- Keep young and beautiful -- it' s your duty to be beautiful
- Outsourcing personal care
- Table 1 Forecast Number of Hotel/Resort Spas by Major Market 2006-2011
- Time pressure, convenience and pampering
- Building ' Brand Me'
- Complexity vs convenience
- Segmentation and chopping the lady in half
- Life' s too short to peel your knees
- Trust me, I' m a doctor
- Chart 7 The Spectrum of Doctor Brands
- High tech ingredients
- Natural and green
- Pale is interesting or tanned to perfection?
- Sunscreen ingredients used as natural pigments in colour cosmetics
- Smile beauty -- the rise of cosmetic dentistry
- Ageing mouths and gums
- Consumer, heal thyself -- the rise of
- self-medication
- Trade off lives -- drugs and supplements to offset indulgence
- Healthy eating -- vitamins and supplements
- Chart 8 Global Value Sales of Vitamins and Dietary Supplements 2006
- Table 2 Top 20 Global Manufacturer Shares of Vitamins and Dietary
Supplements 2005-2006
- Drink yourself well
- KEY MARKET DRIVERS
- Overview
- Beauty and emerging markets
- Adding value -- premiumisation
- Beauty drugs -- cosmeceuticals
- Chart 9 Growth in Global Value Sales of Premium
- Moisturisers/Anti-Agers 2002/2006
- Beauty foods -- the rise of nutricosmetics
- Power foods -- nutraceuticals
- Segmentation -- from age to body parts
- Brands, megabrands and corporations
- Targeted megabrands -- personalisation or complexity?
- The loyalty-novelty conundrum
- Marketing as the differentiator
- New media and word of mouth
- The power of packaging and how green is your wrapping?
- GLOBAL FRAMEWORK AND MAJOR MARKETS
- THE GLOBAL FRAMEWORK
- Chart 10 Interdependence of Market Drivers
- Facial care
- Table 3 Top 10 Companies in Global Facial Care 2002-2006
- MAJOR MARKETS OVERVIEW
- Chart 11 Per Capita Spending on Skin Care in Major Markets 2006
- Chart 12 Market Evolution of Premium Products
- Table 4 Major Markets: Premium and Mass
- Anti-agers/Anti-cellulite Value Sales 2002-2006
- BRAZIL
- Chart 13 Brazil: Anti-agers/Anti-cellulite Value Sales by Type 2006
- Table 5 Brazil: Forecast Sales Value All Cosmetics and
- Toiletries and Premium Market Sector 2007-2011
- CHINA
- Chart 14 China: Skin Care Sales -- Split Between Premium and Mass Brands
2002-2006
- Summary 1 China: Top Premium Skincare Brands (Based on Retail Value RSP)
2006
- Chart 15 China: Dietary Supplements by Benefit 2006
- Table 6 China: Cosmetics and Toiletries Forecast Sales Value 2007-2011
- FRANCE
- Chart 16 France: Anti-agers/Anti-cellulite Value Sales by Type 2006
- Summary 2 France: Top 10 Skincare Brands (Based on Retail Value RSP) 2006
- Chart 17 France: Dietary Supplements by Benefit 2006
- Outlook
- Table 7 France: Forecast Sales Value All Cosmetics and Toiletries and
Premium Market Sector 2007-2011
- ITALY
- Chart 18 Italy: Anti-agers/Anti-cellulite Sales Value by Type 2006
- Summary 3 Italy: Top Premium Skincare Brands (Based on Retail Value RSP)
2006
- Chart 19 Italy: Dietary Supplements by Benefit 2006
- Outlook
- Table 8 Italy: Forecast Sales Value All Cosmetics and Toiletries and
Premium Market Sector 2007-2011
- JAPAN
- Chart 20 Japan: Anti-agers/Anti-cellulite Value Sales by Type 2006
- Summary 4 Japan: Top 10 Premium Skincare Brands (Based on Retail Value
RSP) 2006
- Chart 21 Japan: Dietary Supplements by Benefit 2006
- Outlook
- Table 9 Japan: Forecast Sales Value All Cosmetics and Toiletries and
Premium Market Sector 2007-2011
- RUSSIA
- Chart 22 Russia: Anti-agers/Anti-cellulite Value Sales by Type 2006
- Summary 5 Russia: Top 10 Premium Skincare Brands (Based on
- Retail Value RSP) 2006
- Chart 23 Russia: Dietary Supplements by Benefit 2006
- Outlook
- Table 10 Russia: Forecast Sales Value All Cosmetics and Toiletries and
Premium Market Sector 2007-2011
- SOUTH KOREA
- Summary 6 South Korea: Top 10 Premium Skincare Brands (Based on Retail
Value RSP) 2006
- Table 11 South Korea: Cosmetics and Toiletries Forecast
- Sales Value 2007-2011
- Chart 24 South Korea: Dietary Supplements by Benefit 2006
- SPAIN
- Chart 25 Spain: Anti-agers/Anti-cellulite Sales Value by Type 2006
- Summary 7 Spain: Top 10 Premium Skincare Brands (Based on Retail Value
RSP) 2006
- Outlook
- Table 12 Spain: Forecast Sales Value All Cosmetics and Toiletries and
Premium Market Sector 2007-2011
- UK
- Chart 26 UK: Anti-agers/Anti-cellulite Value Sales by Type
- 2006
- Summary 8 UK: Top 10 Premium Skincare Brands (Based on Retail Value RSP)
2006
- Chart 27 UK: Dietary Supplements by Benefit 2006
- Outlook
- Table 13 UK: Forecast Sales Value All Cosmetics and Toiletries and
Premium Market Sector 2007-2011
- US
- Chart 28 US: Anti-agers/Anti-cellulite Sales Value by Type
- 2006
- Summary 9 US: Top 10 Premium Skincare Brands (Based on Retail Value RSP)
2006
- Chart 29 US: Dietary Supplements by Benefit 2006
- Table 14 US: Forecast Sales Value All Cosmetics and
- Toiletries and Premium Market Sector 2007-2011
- FUTURE OUTLOOK
- From ' anti-ageing' to ' pro youth'
- Skin damage through sun
- 24 hour care regimes
- Nanotechnology
- Fairtrade and ethical
- New rays and computer damage
- Mirror, mirror on the fridge
- Nutrigenomics -- the future of functional food?
- Drink yourself beautiful -- the power of potions
- Convenience in cosmetics/skin care
- Market consolidation at maturity
- Beauty tourism and beauty employment
- Psychonutricosmetics -- make up that makes you feel
- better as well as look better?
- Greater regulation, greater circumvention
- The unending quest for beauty and the psychology of identity
- Status of a simple life
- Inflammation becomes the enemy
- Cross contamination and overlapping effects
- Changing retail structure
- Experiential marketing
- Future scenarios for beauty drugs
- Chart 30 Possible Scenarios for the Future of Beauty
- Drugs
- Beauty flourishes but fragments
- Beauty drugs blossom
- Beauty is beauty, drugs are for doctors
- Beauty becomes a drug
|

|